Skip to main content
. 2014 Apr 30;2014:230346. doi: 10.1155/2014/230346

Figure 7.

Figure 7

Both BM- andAT-derived MSCs when combined to MBCP biomaterial keep their immunosuppressive properties. PBMC from healthy individuals were used as responder cells towards irradiated LCL* used as stimulating cells in presence of either BM-derived MSCs (MSC-BM) or AT-derived MSCs (MSC-AT) that were pretreated with IFNγ and TNFα (IFNγ/TNFα) or not and used as third-party cells at various responder : stimulator : MSC ratios. MSCs were combined to MBCP biomaterial (MBCP) or not (No MBCP). Results are given as mean percentage of alloproliferation inhibition ± s.e.m. when compared to PBMC+LCL* using PBMC from 3 distinct healthy donors.